Frontline nilotinib versus dasatinib in newly diagnosed chronic phase chronic myeloid leukemia: A propensity score analysis based on Agenzia Italiana del Formaco Monitoring Registries
Breccia M et al. Clin Lymphoma Myeloma Leuk, July 2026
Link to full abstract